Trials / Completed
CompletedNCT00802035
ALK29-002: A Study of Baclofen Formulations in Healthy Adults
A Phase 1, Single-Center, Open-Label Study of the Pharmacokinetics of Baclofen Formulations Administered to Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Alkermes, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the pharmacokinetics, safety, and tolerability of different baclofen formulations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Baclofen IR | 30 mg; single dose |
| DRUG | Baclofen ER | 30 mg; single dose |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2008-12-01
- Completion
- 2009-02-01
- First posted
- 2008-12-04
- Last updated
- 2011-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00802035. Inclusion in this directory is not an endorsement.